SE461334B - Cyklosporinderivat, foerfarande foer framstaellning daerav samt farmaceutisk komposition innehaallande naemnda derivat - Google Patents

Cyklosporinderivat, foerfarande foer framstaellning daerav samt farmaceutisk komposition innehaallande naemnda derivat

Info

Publication number
SE461334B
SE461334B SE8501392A SE8501392A SE461334B SE 461334 B SE461334 B SE 461334B SE 8501392 A SE8501392 A SE 8501392A SE 8501392 A SE8501392 A SE 8501392A SE 461334 B SE461334 B SE 461334B
Authority
SE
Sweden
Prior art keywords
cyclosporin
meleu
formula
val
nva
Prior art date
Application number
SE8501392A
Other languages
English (en)
Swedish (sv)
Other versions
SE8501392L (sv
SE8501392D0 (sv
Inventor
R Wenger
R P Traber
H Kobel
H Hofmann
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848407618A external-priority patent/GB8407618D0/en
Priority claimed from GB848411922A external-priority patent/GB8411922D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8501392D0 publication Critical patent/SE8501392D0/xx
Publication of SE8501392L publication Critical patent/SE8501392L/xx
Publication of SE461334B publication Critical patent/SE461334B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/19—Antibiotic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE8501392A 1984-03-23 1985-03-21 Cyklosporinderivat, foerfarande foer framstaellning daerav samt farmaceutisk komposition innehaallande naemnda derivat SE461334B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848407618A GB8407618D0 (en) 1984-03-23 1984-03-23 Organic compounds
GB848411922A GB8411922D0 (en) 1984-05-10 1984-05-10 Organic compounds

Publications (3)

Publication Number Publication Date
SE8501392D0 SE8501392D0 (sv) 1985-03-21
SE8501392L SE8501392L (sv) 1985-09-24
SE461334B true SE461334B (sv) 1990-02-05

Family

ID=26287502

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8501392A SE461334B (sv) 1984-03-23 1985-03-21 Cyklosporinderivat, foerfarande foer framstaellning daerav samt farmaceutisk komposition innehaallande naemnda derivat

Country Status (24)

Country Link
US (1) US4639434A (enExample)
JP (1) JPH08838B2 (enExample)
AT (1) AT388737B (enExample)
BE (1) BE901980A (enExample)
CA (1) CA1247546A (enExample)
CH (1) CH667274A5 (enExample)
CS (1) CS249542B2 (enExample)
DE (1) DE3509809A1 (enExample)
DK (1) DK128285A (enExample)
ES (1) ES8702926A1 (enExample)
FI (1) FI851120L (enExample)
FR (1) FR2561651B1 (enExample)
GB (1) GB2155936B (enExample)
GR (1) GR850716B (enExample)
HU (1) HU200786B (enExample)
IL (1) IL74681A (enExample)
IT (1) IT1199962B (enExample)
LU (1) LU85819A1 (enExample)
NL (1) NL8500828A (enExample)
NO (1) NO851160L (enExample)
NZ (1) NZ211526A (enExample)
PH (2) PH21868A (enExample)
PT (1) PT80149B (enExample)
SE (1) SE461334B (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE92501T1 (de) 1984-10-04 1993-08-15 Sandoz Ag Monoklonale antikoerper gegen zyklosporine.
US4798823A (en) * 1987-06-03 1989-01-17 Merck & Co., Inc. New cyclosporin analogs with modified "C-9 amino acids"
ATE95193T1 (de) * 1987-06-17 1993-10-15 Sandoz Ag Cyclosporine und deren benutzung als arzneimittel.
DE3888357T2 (de) * 1987-06-22 1994-09-15 Merck & Co Inc Cyclosporin-Derivate, die eine modifizierte Aminosäure auf Stellung 8 tragen.
US5227467A (en) * 1987-08-03 1993-07-13 Merck & Co., Inc. Immunosuppressive fluorinated cyclosporin analogs
WO1989001772A1 (en) * 1987-09-03 1989-03-09 University Of Georgia Research Foundation, Inc. Ocular cyclosporin composition
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin
US5089390A (en) * 1987-09-04 1992-02-18 Syntex (U.S.A.) Inc. 2-methyl-4-hexene- and 2-methyl-4-heptene-1,2-diol derivatives
US5236899A (en) * 1987-11-16 1993-08-17 Merck & Co., Inc. 6-position cyclosporin a analogs as modifiers of cytotoxic drug resistance
US4914188A (en) * 1987-11-16 1990-04-03 Merck & Co., Inc. Novel 6-position cyclosporin analogs as non-immunosuppressive antagonists of cyclosporin binding to cyclophilin
CH679119A5 (enExample) * 1988-05-13 1991-12-31 Sandoz Ag
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
GB8916901D0 (en) 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
US5122511A (en) * 1990-02-27 1992-06-16 Merck & Co., Inc. Immunosuppressive cyclosporin analogs with modified amino acids at position-8
US5202310A (en) * 1990-06-06 1993-04-13 Levy Gary A Cyclosporine metabolites
FI111730B (fi) 1990-11-02 2003-09-15 Novartis Ag Menetelmä ei-immunosuppressiivisen syklosporiinin valmistamiseksi
CA2055813A1 (en) * 1990-11-20 1992-05-21 Dariush Davalian Cyclosporin immunoassay
US5747330A (en) * 1996-06-05 1998-05-05 Poli Industria Chimica Antibiotic producing microbe
RU2170741C2 (ru) * 1996-08-16 2001-07-20 Новартис Аг Способ получения циклоспорина
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
DE69832984T2 (de) 1997-10-08 2006-09-21 Isotechnika, Inc., Edmonton DEUTERIERtE und undeuterierte CYCLOSPORIN-ANALOGA UND IHRE VERWENDUNG ALS IMMUNMODULIERENDE AGENtIEN
US5990274A (en) 1997-11-25 1999-11-23 Dade Behring Inc. Cyclosporine derivatives and uses thereof
US7449544B2 (en) * 1999-11-30 2008-11-11 Cyclacel Limited p21 peptides
HRP20070058B1 (hr) 2001-10-19 2014-05-23 Isotechnika Inc. Sinteza ciklosporinskih analoga
EP1435910B9 (en) * 2001-10-19 2010-02-03 Isotechnika Inc. Novel cyclosporin analog microemulsion preconcentrates
CA2518265A1 (en) * 2003-03-17 2004-09-30 Albany Molecular Research, Inc. Novel cyclosporins
JP2008514702A (ja) * 2004-09-29 2008-05-08 エーエムアール テクノロジー インコーポレイテッド 新規シクロスポリン類似体およびそれらの薬学的使用
US7378391B2 (en) * 2004-09-29 2008-05-27 Amr Technology, Inc. Cyclosporin alkyne analogues and their pharmaceutical uses
WO2006041631A2 (en) * 2004-10-06 2006-04-20 Amr Technology, Inc. Novel cyclosporin alkynes and their utility as pharmaceutical agents
US7696165B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
US7696166B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
WO2008069917A2 (en) 2006-11-20 2008-06-12 Scynexis, Inc. Novel cyclic peptides
AU2011342284C1 (en) 2010-12-15 2017-07-13 Contravir Pharmaceuticals, Inc. Cyclosporine analogue molecules modified at amino acid 1 and 3
HUE065915T2 (hu) 2011-03-11 2024-06-28 Beth Israel Deaconess Medical Ct Inc Anti-CD40 antitestek és alkalmazásaik
CN104877013B (zh) * 2015-06-03 2018-04-20 兰州大学 环孢菌素t及其制备方法和应用
WO2017040932A1 (en) 2015-09-04 2017-03-09 Primatope Therapeutics Inc. Humanized anti-cd40 antibodies and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57140753A (en) * 1981-01-09 1982-08-31 Sandoz Ag Novel cyclosporine
DE3260468D1 (en) * 1981-01-09 1984-09-06 Sandoz Ag Novel cyclosporins

Also Published As

Publication number Publication date
ATA86385A (de) 1989-01-15
CA1247546A (en) 1988-12-28
GB8507270D0 (en) 1985-04-24
GB2155936A (en) 1985-10-02
DK128285D0 (da) 1985-03-21
PH21868A (en) 1988-03-25
IT8547852A0 (it) 1985-03-22
IL74681A0 (en) 1985-06-30
GR850716B (enExample) 1985-07-19
PT80149B (en) 1987-03-23
CS249542B2 (en) 1987-03-12
FR2561651A1 (fr) 1985-09-27
HU200786B (en) 1990-08-28
CH667274A5 (de) 1988-09-30
ES541465A0 (es) 1987-01-16
BE901980A (fr) 1985-09-23
NZ211526A (en) 1988-08-30
PH23357A (en) 1989-07-14
DK128285A (da) 1985-09-24
HUT38370A (en) 1986-05-28
NO851160L (no) 1985-09-24
FI851120A7 (fi) 1985-09-24
IT1199962B (it) 1989-01-05
ES8702926A1 (es) 1987-01-16
US4639434A (en) 1987-01-27
SE8501392L (sv) 1985-09-24
PT80149A (en) 1985-04-01
NL8500828A (nl) 1985-10-16
JPH08838B2 (ja) 1996-01-10
FR2561651B1 (fr) 1990-03-09
DE3509809A1 (de) 1986-01-09
GB2155936B (en) 1987-09-16
LU85819A1 (fr) 1985-12-12
FI851120L (fi) 1985-09-24
JPS60215700A (ja) 1985-10-29
SE8501392D0 (sv) 1985-03-21
FI851120A0 (fi) 1985-03-20
IT8547852A1 (it) 1986-09-22
IL74681A (en) 1989-09-10
AT388737B (de) 1989-08-25

Similar Documents

Publication Publication Date Title
US4639434A (en) Novel cyclosporins
US4764503A (en) Novel cyclosporins
US4384996A (en) Novel cyclosporins
JP2740775B2 (ja) 新規シクロスポリン類
JP2772372B2 (ja) シクロスポリン類およびそれらの医薬用途
US5502033A (en) Antimicrobial polypeptide compound a pharmaceutical composition comprising the same, and a method for treating infectious diseases
GB1567201A (en) Sandoz ltd
GB2212499A (en) Cyclosporin analogs as non-immunosuppressive antagonists of cyclosporin binding to cyclophilin
US7375230B2 (en) Fermentation and purification of migrastatin and analog
JPH07258132A (ja) 新規ヒドロキノン化合物
AU596071B2 (en) Novel cyclosporins
JPH0559046A (ja) 免疫調節剤
JPH05331171A (ja) プソイロチンｆ１／ｆ２、アスペルギルス・フミガタスから得られる新規な代謝産物、その調製方法およびその使用
JPH05331172A (ja) 生物活性プソイロチンａおよびｄ、アスペルギルス・フミガタスから得られる新規な代謝産物、その調製方法およびその使用
JPH0338280B2 (enExample)
JP3124373B2 (ja) 免疫抑制物質
JPWO1997043434A1 (ja) 新規生理活性物質及びその製造方法
JP3160409B2 (ja) 抗ｈｉｖ活性ニベフラノン
JPH1129561A (ja) 新規化合物ａｍ６１０５及びその製法
JPH07109299A (ja) 抗ｈｉｖ物質ペスタヒビン及びその誘導体
JPH08301862A (ja) Ｐｅｎｉｃｉｌｌｉｕｍ種の抗生物質シリアノンおよびその化学誘導体並びにその製造法および使用
JPH0892272A (ja) 癌悪液質治療物質ｆｒ１７７３９１
JPH05301857A (ja) Ｗｓ６３９６７物質、その製法及び用途
JPWO1995006045A1 (ja) α−ピロン化合物
JPH06256261A (ja) エンドセリン−１拮抗物質

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8501392-8

Effective date: 19911009

Format of ref document f/p: F